UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Physiological reviews, ISSN 0031-9333, 10/2019, Volume 99, Issue 4, pp. 1877 - 2013
Life Sciences & Biomedicine | Physiology | Science & Technology | Animal models | Parkinson's disease | Mental disorders | Microbiomes | Schizophrenia | Homeostasis | Neurodevelopmental disorders | Neurogenesis | Microbiota | Enteric nervous system | Metabolites | Aging | Anxiety | Vagus nerve | Intestinal microflora | Alzheimer's disease | Movement disorders | Immune system | Neurodegenerative diseases | Peptidoglycans | Tryptophan | Fatty acids | Microglia | Autism | Myelination | Alzheimers disease | Index Medicus
Journal Article
The American heart journal, ISSN 0002-8703, 2015, Volume 170, Issue 5, pp. 865 - 871
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | United States - epidemiology | Primary Health Care - methods | Prevalence | Cross-Sectional Studies | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Risk Factors | Male | Lipids - blood | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Adult | Female | Registries | Hypolipidemic Agents - therapeutic use | Medicine, Experimental | Medical research | Analysis | Cardiac patients | Statins | Cardiovascular agents | Cardiovascular disease | Heart attacks | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
The American heart journal, ISSN 0002-8703, 11/2017, Volume 193, pp. 84 - 92
Primary Health Care - methods | Follow-Up Studies | Humans | Risk Factors | Male | Treatment Outcome | Secondary Prevention - methods | Atherosclerosis - blood | Time Factors | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Lipids - blood | Primary Prevention - methods | Female | Registries | Aged | Disease Management | Retrospective Studies | Atherosclerosis - prevention & control | Blood circulation disorders | Low density lipoproteins | Analysis | Cardiac patients | Coronary heart disease | Statins | Cardiovascular agents | Lipoproteins (low density) | Laboratories | Medical records | Lipids | Cardiovascular disease | Prevention | Cerebrovascular system | Vascular diseases | Education | Atherosclerosis | Cardiology | Heart diseases | Age | Hypertension | Diabetes mellitus | Coronary artery | Health risks | Coronary artery disease | Patients | Cholesterol | Disease prevention | Arteriosclerosis | Adults | Diabetes | Cardiovascular diseases | Community | Index Medicus | Abridged Index Medicus | untreated patients | guideline-recommended treatment | under-treated patients | low-density lipoprotein cholesterol
Journal Article
Psychopharmacology, ISSN 0033-3158, 5/2019, Volume 236, Issue 5, pp. 1671 - 1685
Gut microbiota | Antimicrobial | Short-chain fatty acids | Neurosciences | Biomedicine | Intestinal permeability | Diversity | Richness | Pharmacology/Toxicology | Psychotropics | Psychiatry | Pharmacology & Pharmacy | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Microbiota (Symbiotic organisms) | Fluoxetine | Analysis | Escherichia coli | Physiological aspects | Permeability | Aripiprazole | Mental illness | Drugs | Brain | Antimicrobial activity | Mental disorders | Central nervous system | Microbiomes | Lithium | Biodiversity | Antiinfectives and antibacterials | Citalopram | Psychotropic drugs | Species diversity | Microbiota | Microorganisms | E coli | Intestine | Venlafaxine | Intestinal microflora | Digestive tract | Species richness | Composition | Digestive system | Antimicrobial agents | Valproic acid | Ileum | Side effects | Index Medicus
Journal Article